Well Lead Medical, a Chinese medical devices manufacturer backed by JD Capital, has raised RMB385 million ($61 million) through an IPO in Shanghai.
Greater China | 04 Mar 2015 |
The government-backed Innovation Network corporation of Japan (INCJ), life sciences company JSR Corporation, and pharmaceutical research firm CMIC Holdings have together purchased US-based KBI BioPharma for an undisclosed sum.
North America | 03 Mar 2015 |
Chinese online drugstore 7LK.com has raised RMB300 million ($48 million) in a Series A round of funding from Govtor Capital, Grand Yangtze Capital and TusPark Ventures.
Greater China | 02 Mar 2015 |
TPG Capital has paid INR9 billion ($146 million) for a significant minority stake in healthcare services provider Manipal Health Enterprises (MHE).
South Asia | 27 Feb 2015 |
Malaysia-based GP Navis Capital Partners has agreed to buy Domestic Medical Division (DMD), the cold chain medical equipment unit of Sweden's Domestic Group. The financial terms of the deal were not disclosed.
Southeast Asia | 25 Feb 2015 |
Rainbow Medical, an Israeli medical investment firm, has raised $25 million from a group of Chinese investors including Ping An Insurance and telecom giant ZTE Corporation,financial company Yongjin Group and undisclosed Chinese venture capital funds....
Greater China | 17 Feb 2015 |
Sequoia Capital India and Matrix Partners have invested $30 million in a Series B round of funding for Practo Technologies, an Indian start-up that provides a search portal matching patients and doctors.
South Asia | 13 Feb 2015 |
Vaxxas, an Australian biotechnology start-up developing a novel vaccination platform, has raised a A$25 million ($20 million) Series B round of funding from a group of new and existing investors led by OneVentures.
Australasia | 11 Feb 2015 |
SAIF Partners and Innovation Works have provided a Series A round of funding for Beijing Dnurse Technology, a Chinese company that develops technology used to track sugar levels in the body.
Greater China | 11 Feb 2015 |
MasterLink Securities, the fourth-largest brokerage firm in Taiwan, has won regulatory approval to launch two venture capital investment units in mainland China.
Greater China | 04 Feb 2015 |
Asia Healthcare Fund (AHF) and early-stage player Ventureast have together invested INR400 million in Eye Gear Optics India, the start-up behind optical retail chain Ben Franklin.
Healthcare | 04 Feb 2015 |
AIF Capital has sold its stake in Famy Care, an Indian maker of female oral contraceptives, to US-based pharmaceutical firm Mylan Laboratories for $750 million plus contingent payments of up to $50 million.
Exits | 03 Feb 2015 |
Two PE funds managed by China International Capital Corporation (CICC) will exit Jiangyin Tianjiang Pharmaceutical as China Traditional Chinese Medicine (China TCM) buys a majority stake in the business for up to RMB8.34 billion ($1.34 billion).
Exits | 29 Jan 2015 |
Southeast Asia-focused healthcare investor Quadria Capital, which is expected to close its latest fund in the next two months, has taken a minority stake in Indonesian drug manufacturer Soho Global Health.
Southeast Asia | 27 Jan 2015 |
Legend Capital has led a Series C round of funding worth $100 million for Innovent Biologics, a Chinese biopharmaceutical company.
Healthcare | 27 Jan 2015 |
Updating your subscription status
The outlook for the Australasian market is positive as a record number of IPO exits have provided strong returns for investors and has proven that PE can outperform listed equities and compete with global divestment figures. Fundraising in terms of dollar value has been high but the number of PE funds successfully raising new commitments has declined as investors flock to the best in class.
This is an intriguing time for Australasian PE as the industry continues to mature. GPs must evolve, diversify and display skills to drive value in a low-growth environment and justify future commitments when competing on a global state by achieving world-class results from current deals and exits.
4-6 March 2015, The Westin, Sydney
The AVCJ Indonesia Forum is back for a fourth year! Mark your calendars now and join us on March 24th, 2015 in Jakarta at Indonesia's longest running, largest and most prestigious industry gathering.
The market is relatively optimistic as a new government that is viewed favourable to a balanced investment arena is introduced and we see an increase in deal activity. The hopes for a flourishing PE market amid the euphoria of 2012 has not yet been realised but the potential is still present and now may well be the time for the country to take off in its own right and increase its reputation as THE hot market in Southeast Asia.
24 March 2015, Grand Hyatt, Jakarta